CPZEN-45
Pre-clinical- Indications
- Tuberculosis
Company intelligence / Profile preview
The Institute of Microbial Chemistry (IMC) is a leading Japanese research institute and foundation, globally recognized for the discovery and development of antibiotics and anticancer agents (such as kanamycin, arbekacin, bleomycin, and kasugamycin). It has successfully advanced both human and veterinary drugs, currently maintaining research excellence in basic biology, medicinal chemistry, and disease biology[2][3]. The veterinary drug ZUPREVO (tildipirosin) achieved commercial launch in both Europe and the US[3].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Institute of Microbial Chemistry.